TRAVERE THERAPEUTICS, INC. Deferred Tax Liabilities, Deferred Expense, Other Capitalized Costs

TRAVERE THERAPEUTICS, INC. (TVTX) had Deferred Tax Liabilities, Deferred Expense, Other Capitalized Costs of -$610.00 thousand as of 2013-12-31, per its 10-K/A filed 2015-07-09.

Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Liabilities › Deferred Tax Liabilities, Net › Deferred Tax Liabilities, Gross › Deferred Tax Liabilities, Deferred Expense

us-gaap:DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts · last filed 2015-07-09

2013-12-31: Deferred Tax Liabilities, Deferred Expense, Other Capitalized Costs -$610.00K; Deferred Tax Liabilities, Deferred Expense, Other Capitalized Costs as first filed $610.00.
2012-12-31: Deferred Tax Liabilities, Deferred Expense, Other Capitalized Costs $376.00K; Deferred Tax Liabilities, Deferred Expense, Other Capitalized Costs as first filed -$376.00.

Period end	Deferred Tax Liabilities, Deferred Expense, Other Capitalized Costs	Deferred Tax Liabilities, Deferred Expense, Other Capitalized Costs as first filed
2013-12-31	-$610.00K 10-K/A · filed 2015-07-09	$610.00 10-K · filed 2014-03-28
2012-12-31	$376.00K 10-K/A · filed 2015-07-09	-$376.00 10-K · filed 2014-03-28

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Oruka Therapeutics, Inc. (ORKA)	United States	$5.663B	-43.76
Mirum Pharmaceuticals, Inc. (MIRM)	United States	$5.798B	-8.81
Cogent Biosciences, Inc. (COGT)	United States	$5.450B	-17.61
Gossamer Bio, Inc. (GOSS)	United States	$5.355B	-0.65
PTC THERAPEUTICS, INC. (PTCT)	United States	$5.199B	-177.07
Amneal Pharmaceuticals, Inc. (AMRX)		$6.326B	25.62
Dianthus Therapeutics, Inc. /DE/ (DNTH)	United States	$5.082B	-27.79
Liquidia Corp (LQDA)	United States	$6.347B	51.23
Erasca, Inc. (ERAS)	United States	$5.073B	-19.96
Veradermics, Inc (MANE)	United States	$4.839B